Dianthus Therapeutics | MGTA - Assets

Stock Price
78.90
Daily Change
0.90 1.15%
Monthly
66.21%
Yearly
280.42%
Q1 Forecast
75.51

Dianthus Therapeutics reported $530.92M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Knight Therapeutics CAD 1.05B 10.63M Sep/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Moderna USD 12.34B 203M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Organon & Co USD 13.55B 52M Sep/2025
Ovoca Bio EUR 11.41M 3.36M Jun/2022
Pharma Mar EUR 395.08M 53.42M Dec/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Tilray USD 2.07B 1.33B Mar/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025